Open AccessAdherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine
Author(s) -
R. Someshwaran,
Prakash Kg,
Deshpande Sa,
Aravazhi An
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16084.7382
Subject(s) - medicine , antibiotics , urinary system , ciprofloxacin , norfloxacin , escherichia coli , ofloxacin , antibiotic resistance , intensive care medicine , microbiology and biotechnology , biology , biochemistry , gene
Escherichia coli are the most common uropathogen worldwide accounting for 80% of the Urinary Tract Infections (UTIs). Nosocomial infections caused by Multi-drug resistant Gram negative bacteria expressing Extended Spectrum β Lactamase enzyme, pose a serious therapeutic challenge to clinicians due to limited therapeutic options. Stringent adherence to Hospital Antibiotic Policy in treating Urinary Escherichia coli ESBLs is a borne necessity.